Volker Diehl, MD, of the University of Cologne in Germany, was presented with the Wallace H. Coulter Award for Lifetime Achievement in Hematology at the 2010 American Society of Hematology for his pioneering research in Hodgkin lymphoma for more than 40 years. His scientific achievements include the discovery of the causative role of the Epstein-Barr virus in infectious mononucleosis and the study of its association with Hodgkin lymphoma. He also cultured the first notoriously fragile Hodgkin cell lines and led the development of BEACOPP, a chemotherapy regimen for the treatment of Hodgkin lymphoma. Dr. Diehl also founded the Competence Network Malignant Lymphomas in Germany, which has transformed the way patients with lymphoma are treated within the German health insurance system. Dr. Diehl has devoted his scientific life to the understanding and treatment of Hodgkin lymphoma, and his career is a great example of excellence in translational and clinical research. To learn more about Dr. Diehl, read an article about him in ASH News Daily.

back to Video Library